Please login to the form below

Not currently logged in
PMLiVE Top Pharma List


The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Nexium was produced by AstraZeneca and Daiichi Sankyo.

Race to recovery

One legal case concerns the Supreme Court's order to review the marketing of the top selling ulcer treatment, Nexium.

AZ loses Nexium contract

Research firm Wood Mackenzie estimates the company spends $257m a year on marketing Nexium. ... AZ insists that Nexium is more effective at controlling acid and heals ulcers more quickly than Losec/Prilosec.

Pharma news in brief

Nexium gets FDA nod for use in children. The US Food and Drug Administration (FDA) has given clearance to AstraZeneca to market its heartburn blockbuster, Nexium, for use in children aged ... Nexium had sales of $4.6bn in 2005, making it the fifth

Pharma news in brief

Pfizer's COX-2, Bextra, could give Nexium a further boost, according to industry analysts. ... Many arthritis patients have switched from COX-2 painkillers to a mix of older anti-inflammatories plus a proton pump inhibitor (PPI) such as Nexium.

Pharma news in brief

Health insurer pulls Nexium reimbursement. AstraZeneca (AZ) has been hit by the news that the second largest health insurance firm in the US has decided to discontinue reimbursement for its ... United Healthcare said it plans to halve its $300m bill for

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs


Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...